-
Article
Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY)
Defining the risk of atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients is an important clinical and prognostic challenge. The aim of this study is to determine HCM phenogroups with differe...
-
Article
Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 map**
In Anderson-Fabry disease (FD), we sought to evaluate relation between left ventricular (LV) hypertrophy, longitudinal strain (LS), myocardial T1 map** and cardiopulmonary exercise parameters, and their prog...
-
Article
Characterization of hypertrophic cardiomyopathy according to global, regional, and multi-layer longitudinal strain analysis, and prediction of sudden cardiac death
To evaluate the severity of hypertrophic cardiomyopathy (HCM) according to global, regional, and multi-layer longitudinal strain (LS) analysis using speckle-tracking echocardiography. From February 2007 to Nov...
-
Article
Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography
To evaluate if morphological or functional abnormalities could be detected with echocardiography in hypertrophic myocardiopathy (HCM) mutation carriers without left ventricle (LV) hypertrophy has developed. HC...
-
Article
Open AccessThe embryological basis of subclinical hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomeric proteins, the commonest being MYBPC3 encoding myosin-binding protein C. It is characterised by left ventricular hypertrophy but there is an i...
-
Article
Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy
The aim of this cohort study was to evaluate the value of echocardiographic multilayer strain analysis in the identification of arrhythmogenic cardiomyopathy (AC) in its earliest stages in which sudden cardiac...
-
Article
Open AccessIt's not just the mitral valve - abnormal motion of the whole aorto-mitral apparatus occurs in both overt and subclinical hypertrophic cardiomyopathy
-
Article
Open AccessChronic iron deposit and left ventricular remodeling in reperfused STEMI patients
-
Article
Open AccessDiffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study
-
Article
Open AccessLeft ventricular remodeling after reperfused acute myocardial infarction: insights from automated ECV map**
-
Article
Open AccessAbnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
Sarcomeric gene mutations cause hypertrophic cardiomyopathy (HCM). In gene mutation carriers without left ventricular (LV) hypertrophy (G + LVH-), subclinical imaging biomarkers are recognized as predictors of...
-
Article
Open AccessCMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
-
Article
Open AccessT1 map** in severe aortic stenosis: insights into LV remodeling
-
Article
Open AccessLGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
-
Article
Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy
Longitudinal strain analysis enables early detection of left ventricular (LV) contraction abnormalities in patients with preserved ejection fraction. Hypertrophic cardiomyopathy (HCM) is associated with low v...
